生物技术进展 ›› 2016, Vol. 6 ›› Issue (3): 179-184.DOI: 10.3969/j.issn.2095-2341.2016.03.05

• 进展评述 • 上一篇    下一篇

介孔二氧化硅在癌症化疗药物控释和靶向输送中的应用进展

穆京海,叶舟,张权*,尹健*   

  1. 江南大学生物工程学院, 糖化学与生物技术教育部重点实验室, 江苏 无锡 214122
  • 收稿日期:2016-02-22 出版日期:2016-05-25 发布日期:2016-03-15
  • 通讯作者: 张权,副教授,主要从事智能靶向和控释药物输送系统研究。Tel:0510-85197039; E-mail:quanzhang@jiangnan.edu.cn; 尹健,教授,主要从事糖生物工程研究。Tel:0510-85328229; E-mail:jianyin@jiangnan.edu.cn
  • 作者简介:穆京海,硕士研究生,主要从事介孔硅药物输送系统研究。E-mail:6130205019@vip.jiangnan.edu.cn。
  • 基金资助:

    国家自然科学基金(51403081);江苏省自然科学基金(BK20140137)资助。

Progress on Application of Mesoporous Silica Nanoparticles  in Controlled Drug Release and Targeted Drug Delivery of Cancer Chemotherapy

MU Jing-hai, YE Zhou, ZHANG Quan, YIN Jian   

  1. Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology,
    Jiangnan University, Jiangsu Wuxi 214122, China
  • Received:2016-02-22 Online:2016-05-25 Published:2016-03-15

摘要: 癌症化疗往往会给患者带来极大的毒副作用,开发新型具有可控药物释放和靶向药物输送功能的纳米材料是提高抗癌药物输送 药效和降低毒副作用的关键。介孔二氧化硅的高比表面积、均一介孔结构、可控粒子尺寸、易于进行化学修饰等性能使其非常 适合作为可控药物释放和靶向治疗癌症的优良载体系统。概括了最近几年介孔二氧化硅在药物控制释放和靶向药物输送治疗癌 症中的研究进展,并展望了介孔二氧化硅纳米材料作为药物输送系统在癌症治疗方面未来的发展方向。

关键词: 癌症化疗, 介孔二氧化硅, 可控药物释放, 靶向药物输送

Abstract: Cancer chemotherapy normally produces systemic toxicity and undesired side effects on patients. In order to improve the chemotherapy, its desiderated to develop new type of nanomaterials for controlled drug release and targeted drug delivery. Mesoporous silica nanoparticles (MSNs) have attracted much attention for their potential use as drug delivery carriers. The unique properties of MSNs, such as high surface area, uniform mesoporous, tunable nanoparticle size and easy chemical functionalization, make them highly suitable as a therapeutic delivery vehicle. This article reviewed recent progress on controlled drug release and targeted drug delivery of MSNs, and prospected development as drug delivery carriers for cancer therapy.

Key words: cancer chemotherapy, mesoporous silica nanoparticles, controlled drug release, targeted drug delivery